These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23531448)

  • 1. MicroRNA and cancer chemoprevention.
    Yi B; Piazza GA; Su X; Xi Y
    Cancer Prev Res (Phila); 2013 May; 6(5):401-9. PubMed ID: 23531448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents.
    Qian B; Nag SA; Su Y; Voruganti S; Qin JJ; Zhang R; Cho WC
    Curr Cancer Drug Targets; 2013 Jun; 13(5):519-41. PubMed ID: 23597193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research.
    Li Y; Kong D; Wang Z; Sarkar FH
    Pharm Res; 2010 Jun; 27(6):1027-41. PubMed ID: 20306121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
    Ahadi A
    IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of microRNAs by natural agents: new strategies in cancer therapies.
    Phuah NH; Nagoor NH
    Biomed Res Int; 2014; 2014():804510. PubMed ID: 25254214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-21: a ubiquitously expressed pro-survival factor in cancer and other diseases.
    Li S; Liang Z; Xu L; Zou F
    Mol Cell Biochem; 2012 Jan; 360(1-2):147-58. PubMed ID: 21909994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of MicroRNAs by Phytochemicals: A Promising Strategy for Cancer Chemoprevention.
    Babashah S; Bakhshinejad B; Birgani MT; Pakravan K; Cho WC
    Curr Cancer Drug Targets; 2018; 18(7):640-651. PubMed ID: 28669335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the regulatory role of microRNA in tumor angiogenesis and clinical implications.
    Wang Y; Wang L; Chen C; Chu X
    Mol Cancer; 2018 Feb; 17(1):22. PubMed ID: 29415727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiRNA-based Therapeutics for Lung Cancer.
    Wu M; Wang G; Tian W; Deng Y; Xu Y
    Curr Pharm Des; 2018 Feb; 23(39):5989-5996. PubMed ID: 28714413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenesis and Tumor Inhibition by MicroRNAs and its Potential Therapeutic Applications: A Systematic Review.
    Karkhane M; Lashgarian HE; Hormozi M; Fallahi S; Cheraghipour K; Marzban A
    Microrna; 2020; 9(3):198-215. PubMed ID: 31686643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-224: as a potential target for miR-based therapy of cancer.
    Chen W; Fan XM; Mao L; Zhang JY; Li J; Wu JZ; Tang JH
    Tumour Biol; 2015 Sep; 36(9):6645-52. PubMed ID: 26254100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavonoid display ability to target microRNAs in cancer pathogenesis.
    Singh S; Raza W; Parveen S; Meena A; Luqman S
    Biochem Pharmacol; 2021 Jul; 189():114409. PubMed ID: 33428895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA targeting by quercetin in cancer treatment and chemoprotection.
    Kim DH; Khan H; Ullah H; Hassan STS; Ċ mejkal K; Efferth T; Mahomoodally MF; Xu S; Habtemariam S; Filosa R; Lagoa R; Rengasamy KR
    Pharmacol Res; 2019 Sep; 147():104346. PubMed ID: 31295570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs as anti-cancer therapy.
    Garofalo M; Leva GD; Croce CM
    Curr Pharm Des; 2014; 20(33):5328-35. PubMed ID: 24479801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microRNA-200 family: small molecules with novel roles in cancer development, progression and therapy.
    Humphries B; Yang C
    Oncotarget; 2015 Mar; 6(9):6472-98. PubMed ID: 25762624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of miR-100 in cancer diagnosis, prognosis, and therapy.
    Qin C; Huang RY; Wang ZX
    Tumour Biol; 2015 Mar; 36(3):1403-9. PubMed ID: 25740059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging roles for modulation of microRNA signatures in cancer chemoprevention.
    Neelakandan K; Babu P; Nair S
    Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities.
    Asadzadeh Z; Mansoori B; Mohammadi A; Aghajani M; Haji-Asgarzadeh K; Safarzadeh E; Mokhtarzadeh A; Duijf PHG; Baradaran B
    J Cell Physiol; 2019 Jul; 234(7):10002-10017. PubMed ID: 30537109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs: biogenesis, roles for carcinogenesis and as potential biomarkers for cancer diagnosis and prognosis.
    Kavitha N; Vijayarathna S; Jothy SL; Oon CE; Chen Y; Kanwar JR; Sasidharan S
    Asian Pac J Cancer Prev; 2014; 15(18):7489-97. PubMed ID: 25292018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.